Advisor Group’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Advisor Group’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$14K	Sell	600 -100	-14%	-$2.22K	﹤0.01%	4164
2019 Q3	$15K	Sell	700 -500	-42%	-$10.9K	﹤0.01%	4144
2019 Q2	$25K	Buy	1,200 +100	+9%	+$2.11K	﹤0.01%	3849
2019 Q1	$24K	Sell	1,100 -820	-43%	-$17.5K	﹤0.01%	3898
2018 Q4	$41K	Sell	1,920 -1,335	-41%	-$30.5K	﹤0.01%	3339
2018 Q3	$83K	Sell	3,255 -215	-6%	-$5.46K	﹤0.01%	2892
2018 Q2	$88K	Hold	3,470	–	–	﹤0.01%	2631
2018 Q1	$86K	Buy	+3,470	New	+$89.1K	﹤0.01%	2674

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisor Group's LDRS Position: Q4 2019 in Review

Advisor Group reduced its Innovator IBD ETF Leaders ETF (LDRS) stake by 14% in Q4 2019, selling an estimated $2.22K and leaving 600 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.

Advisor Group first reported a position in LDRS in Q1 2018 and has held it in 8 quarters since. The position peaked at $88K in Q2 2018. 10 funds tracked by Wall St. Rank hold LDRS as of Q4 2019.

Advisor Group held 600 shares of Innovator IBD ETF Leaders ETF worth $14K as of Q4 2019.
Advisor Group sold 100 Innovator IBD ETF Leaders ETF shares in Q4 2019, an estimated $2.22K.
Innovator IBD ETF Leaders ETF made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4164 holding.
Advisor Group first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and has held it in 8 quarters since.
Advisor Group's Innovator IBD ETF Leaders ETF position peaked at $88K in Q2 2018.
10 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.